It’s the height of meeting season! All our most-read stories this month hailed from the news team’s on-site coverage.

One question, in light of FREEDOM, is how well new DES compare with CABG in patients with diabetes and multivessel disease.

Physicians will remain in the loop, but AI can “turbocharge and augment our abilities,” an emergency medicine physician says.

Changes are afoot to meet higher caseloads amid rising demand, the survey of 6,830 cardiovascular providers suggests.

Bioadaptor was designed to restore normal vessel function and reduce late stent-related complications. It’s working so far.

The national coverage determination explicitly outlines patient, clinician, and facilities criteria for qualifying procedures ...

Mamas Mamas, Ruben de Winter, and Paul Knaapen discuss the results of the PROCTOR trial, which explored native vessel versus ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

Modern is consistent with the literature in this space, but the trial shows that a staged complete procedure might be just ...

Having more-thorough workup uncovered an unexpected root cause and changed the treatment course for 76% of patients.

The saphenous vein grafts treated in the RCT were relatively straightforward, while the native vessels were largely CTOs.

The intracoronary fibrinolysis infusion joins a host of other failed treatments to improve microvascular obstruction after ...